NASDAQIMMY

Founder and CEO
Board member

Mr. Baum is a founder, member of the board of directors and chief executive officer of Imprimis. Read More

Chief Financial Officer

Mr. Boll joined Imprimis in December 2011 as a consultant until he was hired as Vice President of Accounting and Public Reporting (Principal Financial and Accounting Officer) of the company in February 2012. Read More

Chief Commercial Officer

Mr. Saharek started with Imprimis as Vice President of Commercialization, Ophthalmology in November 2013 until his promotion to Chief Commercial Officer in February 2015. Read More

Vice President, Business Development

Mr. Seelhorst has been the Vice-President, Business Development of Imprimis since July 2013 and is responsible for licensing agreements and pursuing partnerships with insurance companies, pharmacy benefit managers, ambulatory surgery centers and national physician networks. Read More

Senior Vice President, Operations

Mr. Edwards joined Imprimis in August 2016 as Senior Vice President of Operations where he oversees the company’s pharmacy operations, including production, dispensing and customer service. Read More

Vice President, Client Relations

Mr. Rice has been the Vice President of Client Relations at Imprimis since July 2016 and is responsible for implementing new processes to improve efficiencies with the ultimate goal of building Imprimis’ customer service department into a center of excellence. Read More

Vice President, Quality

Mr. Sharma has been the Vice President of Quality since August 2016 and oversees the expansion of all Imprimis quality systems in line with the highest pharmaceutical and compounding industry standards. Read More

Vice President, Manufacturing

Mr. Samudre has been the Vice President of Manufacturing at Imprimis since May 2016 where he oversees supply chain and production while adding automation and scalability to many the company’s core compounded formulations. Read More

Intellectual Property Counsel

Dr. Repkin has served as patent attorney and intellectual property counsel for Imprimis since June 2013. Read More

Director of Investor Relations & Corporate Communications

Ms. Ortega has 20 years of experience building and managing investor and media relations programs for publicly-traded biotechnology, pharmaceutical and medical device companies. Read More

Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.


print email